Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds

  • Yong Yao Loh
  • , Kazunori Nagao
  • , Andrew J. Hoover
  • , David Hesk
  • , Nelo R. Rivera
  • , Steven L. Colletti
  • , Ian W. Davies
  • , David W.C. MacMillan

Research output: Contribution to journalArticlepeer-review

454 Scopus citations

Abstract

Deuterium- and tritium-labeled pharmaceutical compounds are pivotal diagnostic tools in drug discovery research, providing vital information about the biological fate of drugs and drug metabolites. Herein we demonstrate that a photoredox-mediated hydrogen atom transfer protocol can efficiently and selectively install deuterium (D) and tritium (T) at a-amino sp3 carbon-hydrogen bonds in a single step, using isotopically labeled water (D2O or T2O) as the source of hydrogen isotope. In this context, we also report a convenient synthesis of T2O from T2, providing access to high-specific-activity T2O. This protocol has been successfully applied to the high incorporation of deuterium and tritium in 18 drug molecules, which meet the requirements for use in ligand-binding assays and absorption, distribution, metabolism, and excretion studies.

Original languageEnglish (US)
Pages (from-to)1182-1187
Number of pages6
JournalScience
Volume358
Issue number6367
DOIs
StatePublished - Dec 1 2017

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds'. Together they form a unique fingerprint.

Cite this